← Back to Bills
HR 8564118th CongressFailed / ExpiredHouse

Elevating Biotechnology Threats Reporting Act

Policy Area: Armed Forces and National Security
View on Congress.gov
Origin Chamber
House
Last Updated
Oct 25, 2024
Latest Action Date
May 23, 2024

Latest Action

Referred to the House Committee on Intelligence (Permanent Select).

Official Summary

Official summary has not been imported yet.

GovScope Watchdog™

AI Government Intelligence™
Executive Summary

The Elevating Biotechnology Threats Reporting Act (H.R. 8564) was a bill introduced in the 118th Congress aimed at addressing issues related to biotechnology threats within the context of armed forces and national security. The bill was referred to the House Committee on Intelligence (Permanent Select) on May 23, 2024, but no further legislative action or detailed text is publicly available. The bill's summary and full text have not been provided, limiting detailed analysis of its provisions or mechanisms.

Bottom Line

H.R. 8564 sought to enhance reporting mechanisms for biotechnology threats in national security but did not advance beyond committee referral and ultimately expired without passage.

Policy Risk Level
🟡 Medium
Neutral Risk Assessment
Key Points
  • The bill was introduced in the House during the 118th Congress and referred to the House Committee on Intelligence.
  • It falls under the policy area of Armed Forces and National Security, indicating a focus on national defense-related biotechnology concerns.
  • No official summary or full text is available, restricting detailed understanding of its specific provisions or requirements.
Who Benefits?

['Federal agencies involved in national security and intelligence, particularly those monitoring biotechnology threats.', 'The armed forces and national security apparatus potentially benefiting from improved threat reporting.', 'Potentially the biotechnology sector if the bill includes provisions for threat identification and mitigation.']

Potential Concerns

["Lack of publicly available full text and summary limits transparency and understanding of the bill's scope and implementation requirements.", 'Unclear funding mechanisms or enforcement provisions due to missing detailed legislative text.', 'Potential challenges in oversight and authority distribution among intelligence and defense agencies.']

Political Context

The bill was introduced during the 118th Congress and referred to the House Committee on Intelligence but did not progress further, ultimately failing or expiring. Its focus on biotechnology threats aligns with growing legislative interest in emerging security risks related to biotechnology within the national defense framework.

Hidden Impact Review

Hidden impact flags detected: 1

GovScope reviewed 1 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.

1 Detected
Detected Flags
Indirect Effects

['If enacted, the bill could lead to enhanced coordination and reporting on biotechnology threats, potentially improving national security preparedness.', 'Improved reporting mechanisms might increase administrative workload for intelligence and defense agencies.', 'Potentially increased scrutiny or regulation of biotechnology research and development sectors.']

GovScope Watchdog Notes

The absence of an official summary and full bill text presents a significant transparency gap, making it difficult for the public and oversight bodies to evaluate the bill's intent, scope, and potential impacts. Future legislative proposals should ensure timely publication of complete texts and summaries to facilitate informed analysis and accountability.

Passage Likelihood: LowConfidence: 60%Model: gpt-4.1-mini

GovScope Intelligence Roadmap

Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.

Enterprise Ready